Literature DB >> 11431237

Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum.

W G Staal1, H E Hulshoff Pol, H G Schnack, N E van Haren, N Seifert, R S Kahn.   

Abstract

OBJECTIVE: This study investigated the relationship between outcome and structural brain abnormalities in schizophrenia.
METHOD: Intracranial volume and volumes of the cerebrum, gray and white matter, lateral and third ventricles, frontal lobes, thalamus, and cerebellum were measured in 20 patients with a poor outcome, 25 with a favorable outcome, and 23 healthy comparison subjects with magnetic resonance imaging.
RESULTS: Thalamic volume was significantly smaller both in poor-outcome patients and good-outcome patients. In contrast, only poor-outcome patients displayed significantly smaller cerebral gray matter, particularly prefrontal, and enlargement of the lateral and third ventricles. No significant differences were found for intracranial, cerebellar, or cortical CSF volumes.
CONCLUSIONS: Smaller thalamic volumes in schizophrenia may reflect a greater susceptibility for the disorder and seem unrelated to outcome. In contrast, gray matter volume loss of the cerebrum, particularly in the frontal lobes, and lateral and third ventricular enlargement appear related to outcome in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431237     DOI: 10.1176/appi.ajp.158.7.1140

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

Review 1.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 2.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 3.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

4.  Cerebellar volume in schizophrenia and bipolar I disorder with and without psychotic features.

Authors:  C Laidi; M-A d'Albis; M Wessa; J Linke; M L Phillips; M Delavest; F Bellivier; A Versace; J Almeida; S Sarrazin; C Poupon; K Le Dudal; C Daban; N Hamdani; M Leboyer; J Houenou
Journal:  Acta Psychiatr Scand       Date:  2014-11-28       Impact factor: 6.392

5.  Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.

Authors:  T Moberget; N T Doan; D Alnæs; T Kaufmann; A Córdova-Palomera; T V Lagerberg; J Diedrichsen; E Schwarz; M Zink; S Eisenacher; P Kirsch; E G Jönsson; H Fatouros-Bergman; L Flyckt; G Pergola; T Quarto; A Bertolino; D Barch; A Meyer-Lindenberg; I Agartz; O A Andreassen; L T Westlye
Journal:  Mol Psychiatry       Date:  2017-05-16       Impact factor: 15.992

6.  Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response.

Authors:  K A Barksdale; A C Lahti; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2014-03-07       Impact factor: 7.853

Review 7.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  Volumetric and shape analysis of the thalamus in first-episode schizophrenia.

Authors:  Denise M Coscia; Katherine L Narr; Delbert G Robinson; Liberty S Hamilton; Serge Sevy; Katherine E Burdick; Handan Gunduz-Bruce; Joanne McCormack; Robert M Bilder; Philip R Szeszko
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

9.  Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response.

Authors:  Rosalinda C Roberts; Joy K Roche; Robert R Conley; Adrienne C Lahti
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

10.  Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model.

Authors:  Qi Li; Charlton Cheung; Ran Wei; Edward S Hui; Joram Feldon; Urs Meyer; Sookja Chung; Siew E Chua; Pak C Sham; Ed X Wu; Grainne M McAlonan
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.